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ABSTRACT
Machine Learning and Artificial Intelligence have made significant progress
concurrent with new advancements in hardware and software technologies. Deep learning
methods heavily utilize parallel computing and Graphical Processing Units(GPU). It is
already used in many applications ranging from image classification, object detection,
segmentation, cyber security problems and others. Deep Learning is emerging as a viable
choice in dealing with today’s real-time medical problems. We need new methods and
technologies in the field of Medical Science and Epidemiology for detecting and
diagnosing emerging threats from new viruses such as COVID-19. The use of Artificial
Intelligence in these domains is becoming more accepted, not as a replacement for
current medical practices but rather as an enhancing and augmenting tool to current
practices. This dissertation is about the Application of Deep Learning for Medical
Sciences and Epidemiology Data analysis and Diagnosis Modeling. The work started
with an analysis of existing data, then focused on developing diagnosis models using both
supervised and unsupervised approaches. This resulted in a renal transplantation
recommender system, breast cancer diagnosis model and COVID-19 diagnosis models.
The recent completed work for COVID-19 diagnosis modeling leverage the potential of
more advanced deep neural network model and vision transformer. The results are very
promising and outperformed all existing models. The final diagnosis model has three
kinds of dataset. For Chest X-Ray(CXR) image dataset training accuracy is 95.9376 %,
validation accuracy is 96.1667 % and testing accuracy is 95.1250 %. For Chest CT image
dataset training accuracy is 96.5474 %, validation accuracy is 95.7302 % and testing
accuracy is 97.0588 %. For the Combined CXR and Chest CT image dataset training
ii

accuracy is 95.6665 %, validation accuracy is 96.6961% and testing accuracy is 97.8859
%.
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CHAPTER I - INTRODUCTION
This chapter starts with the motivation behind the present work and then presents
a brief overview of the fields of Artificial Intelligence and Machine Learning and Deep
Learning, in particular. After that it presents an overview of the datasets available and
used in the present work. We have many publications and many are under review. One
conference paper was awarded the best paper award and a journal article is featured at
World Health Organization(WHO)’s website for global research on COVID-19
pandemic.
1.1 Motivation
Initially, the work started with the exploration of possible domain of artificial
intelligence and machine learning research fields. Extensive literature studies on
supervised learning methodologies, semi-supervised learning methodologies,
unsupervised learning methodologies helped to formulate the path by which we can
design our model and solve different kinds of problems which are of current interest. The
initial work started with the renal transplantation model design, then the design of
predictive model for breast cancer was developed both using unsupervised and
supervised approaches. When the COVID-19 pandemic broke out our focus shifted to
designing machine learning models to help in the understanding of this pandemic and
come up with practical solutions. The initial problem was the lack of information and
data related to the COVID-19 pandemic. But, gradually the research community, medical
fraternity and other resources made data available online so we can start analyzing those
and build up our problem solving models. We were able to develop many models to
design diagnosis model for COVID-19 using deep learning methodologies. We initially
1

developed a prognosis model for COVID-19 detection using Chest X-ray(CXR) image
data, then we designed an ensemble model, then we designed a prognosis model using
Chest Computer Tomography(CT) images. Recently, we also successfully developed
integration of transformative and convolutional neural network using a combination of
CXR, CT images.
1.2 Artificial Intelligence
“AI is the study of complex information processing problems that often have
their roots in some aspect of biological information processing. The goal of the subject is
to identify solvable and interesting information processing problems and solve them.”
− David Marr, Computational neuroscientist and physiologist.
“The intelligent connection of perception to action”
− Rodney Brooks, Artificial Intelligence Scientist
“Actions that are indistinguishable from a human’s”
− Alan Turing, Father of theoretical computer science and artificial intelligence
Artificial Intelligence(AI) is revolutionizing every aspect of our daily life and is
already used widely in a number of disciplines. The term AI is used in a more generic
sense in today’s computational work. It integrates and give birth to many revolutionary
technologies like neural networks, deep learning, representation learning, reinforcement
learning to name a few. One could say that it all started form the ‘Turing Test’
experiment by Alan Turing in 1950, where in order to pass the Turing test a machine’s
action should become distinguishable from a human’s actions as observed by another
human. Once this goal was set, a paradigm shift happened in the above fields with
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revolutionary research by thousands of scientists all around the world. The following Fig.
1.1 illustrates the recent scenario of research area in an abstract way.

Figure 1.1 The abstract representation of Artificial Intelligence and related branches
The artificial intelligences comprises of many technologies and theoretical fields, like
Machine learning, Neural Network, Deep Learning, representation learning and
explainable Artificial Intelligence(XAI). Also, reinforcement learning is getting
popularity in the field of simulations, agent based learning, multi-agent learning, game
design, etc. In the following sections will gives brief introduction about those fields
which we actually use in this work and have relevant publication related to this thesis.
1.3 Machine Learning
Machine learning has evolved a lot in the last two decades and we now also have
more sophisticated hardware with large memory resources available both in local
machines and in the virtual cloud machine. Data centers, cloud services have contributed
a lot for the growth of machine learning as the core of machine learning involves working
with data. Huge amount of data processing is an integral part of machine learning
domain. Data could be in any form like raw data, satellite data, image data, video data,
audio data or any combination of multimedia data or signals. If we wish to design a
3

machine learning model we need to have the data, essentially a large amount of data can
help a lot in designing the model in a robust way. The design and performance of the
model also depends heavily on the preprocessing of the data as well. This varies a lot
depending upon which type of model we are focusing on. For supervised machine
learning methodologies the data annotations and labeling is an important aspect of design
the model. Preprocessing deals with how we can refine the data so that it should fit
appropriately with the model, especially when we have many missing values or null
values. Practically machine learning problems deals with realistic problem solving and
designing model with the help of data. So, meaning data extraction, effective feature
extraction and automatic processing is an integral part of the system, but those realistic
problems have many missing values or null values in their parameters. The parameters
are the attributes by which we understand the system and try to model using different
model design techniques such as whether it is regression problem, classification problem,
segmentation problem or object detection problem. Most datasets for all kinds of realistic
problem domains have those missing values and null values. So, we can write codes
which can delete those values or replaced it with some constant values. In many times we
also perform many operations to convert non-numerical categorical data, like yes or no,
benign or malignant to have a numerical value so that computer system can understand it
in proper way as data is considered as a vector or tensor in the machine learning model.
Another kinds of data preprocessing involves with the operation of standardizing the
dataset. It require deep understanding of the problem domain and how we are going to
standardize those values. Understanding the data and preprocessing also help to recognize
which model is best suited for that particular dataset, whether it require nonlinear model
4

or linear model or simple mathematical model and statistical model can solve the
problem. The analysis of the dataset and its complexity is the fundamental part of any
machine learning model design. The Machine learning model require a board range of
mathematical and statistical understanding as well. Like for regression problem analysis,
we often use linear algebra and vector calculus. Likewise for classification problem,
optimization theories and matrix decomposition methods are widely used.
1.4 Deep Learning
Deep Learning(DL) nowadays is getting more popularity as it has successfully
provided leading results in many regression, classification and other kinds of problem
settings.
Deep learning is the way by which we introduce more hidden layers in a neural
network and design algorithms which can process the data in a faster way, say, using
multiple GPUs, than the traditional machine learning methods. Deep learning generally
uses parallel processing concepts and due to the advancement of multi-core central
processing unit(CPU) and Graphical Processing Unit(GPU) those theoretical concepts are
now implemented exploiting these advanced hardware support. Deep multiple layers in
the neural network architecture of DL systems are called as Deep Neural Network(DNN).
It is more useful for complex data representation understanding and extract feature which
are more robust, and accurate. It is currently providing breakthrough results in intensive
data analytics problems including Big-data problems, image processing and image
classification, image segmentation and image object detection, video image analysis and
video processing problems, audio analysis and speech recognition, Natural language
Processing(NLP), cyber security to name a few. These applications cover different
5

industry sectors like computer vision, public health, education, transportation, robotics,
airline industries, drug discovery, bio-informatics, cyber security and others. Deep
learning also gaining remarkable success in the field of agent learning, multi-agent
learning, Simulation design, reinforcement learning and other kinds of representation
learning. Deep learning is very much synonymous with advanced statistical machine
learning and advanced artificial intelligence techniques.
1.5 Medical Data Analysis and Prognosis Model Design
The use of Machine Learning(ML) and Artificial Intelligence(AI) in the field of
medical and epidemiological data analytics and diagnostic modeling, open new window
of hopes and revolutionize the field. The perspective of solving problems in this domain
changed remarkable by the use of automated systems and diagnostic tools. Artificial
Intelligence (AI) has been brought into medical practice because it is helping to save
thousands of human lives. AI has become the essential choice for solving emerging
medical problems. As novel viruses challenge conventional solutions, a trending
introspection in the field of Medical Science and Epidemiology constantly draws on AIpowered resources such as innovative real-time tools to make up for identifiable
shortcomings. Thus, AI provides an indispensable, complementary support to current
medical practice, empowering the global health system to respond effectively to present
and future emergencies. AI provides innovative real-time tools with essential support to
boost the responsiveness of medical practice to life-threatening challenges. The
interconnection of unattended network devices incorporating sensors (aka things) form
the Internet of Things (IoT) whose functions can be bolstered using AI, especially in
medical fields. The things and the AI that powers them make up the Artificial
6

Intelligence of Things (AIoT). In medical practice, image data capturing devices such as
smartphones and other wearable devices are useful for measuring human health
parameters. The measuring process involves obtaining and monitoring real time health
data such as parameter values obtained from patients or any healthy human being. Heart,
diabetes, and blood temperature parameters are some examples of the parameter values.
Human health related data can be obtained by using our smartphone and some wearable
devices the human health parameters can be easily measured. Those parameter values
received from the patient or any healthy human being could be as follows,
1) Heart Parameters: Like heart rate, oxygen saturation, heart rate variability even
Electrocardiography(ECG).
2) Blood Pressure and Temperature sensor etc.
3) Diabetics parameters: Like glucose measurement, heart rate, etc.
4) Image capturing devices

Figure 1.2 The Remote Human health monitoring system
Figure 1.2 shows how with the integration of internet of thing(IoT), big-data,
mobile cloud computing we can easily automate the process of monitoring human health
by AI techniques. It would process the data in real time, then after analyzing and
identifying the issue it would provide recommended guidelines along with a report of
different health parameters. The availability of wide range of medical open access
7

datasets online and the availability of approval-based datasets online, ranging from
radiological image dataset, different disease related analytical dataset has provided much
help to build different deep learning models rapidly with high efficiency. Many imagecapturing systems are able to produce radiological image data and feeding such images to
a Deep Learning model could lead to the detection of many kinds of diseases in near realtime. At the least they can provide valuable information to radiologists regarding that
disease. One of our recent publications is in this regard where an automated system can
detect COVID-19 using Chest X-Ray images. This research is already featured on the
official website of the World Health Organization(WHO) on COVID-19 Global literature
on Coronavirus Disease.

8

CHAPTER II - LITERATURE REVIEW

This chapter would provide the literature related to our research work and
showing the research potential, limitations and shortcoming. Our journey started with the
reading and conceptualization the famous work of Alan Turing[1], where he proposed to
consider the question, “Can machines think?” with his elaboration of imitation game.
This article was published in 1950 at the British Journal named Mind. Then we make
comprehensive understanding from the artificial intelligence book[2], which mainly
focuses on modern approach and practices in this field. Then we study different
application domains of AI, namely education[3], Communication[4], Transportation[5],
Agriculture[6], Entertainment, Finance[7], Public health sector[8-10]. The book
chapter[11] on category identification is also review many works related to feature
generation. The next section will shows the literature review related to our work on
application of deep learning for medical sciences and epidemiology data analytics and
diagnostic modeling.
2.1 Survival Prediction Model for Renal Transplantation
Successful Organ Transplantation (OT) saves thousands of life all over the world and it is
now a common practice everywhere. Hence, there are many research works done for
different kinds of OT. Renal Transplantation, Liver Transplantation, Heart
Transplantation, Islet transplantation for Type-1 Diabetic patients etc. are now very
popular and successful treatment facilities available for medical practitioners around the
world. F. Locatelli et. al. [12] describe about the basic areas of renal treatment, where
they are emphasizing on peritoneal dialysis (PD) and renal transplantation as a successful
9

medical treatment. On average, 95 transplants take place each day in the USA alone.
Scientific Registry of Transplant Recipients (SRTR), USA, records all ongoing
evaluation of the scientific and clinical status of solid organ transplantation. In the USA
in the year 1995, the United Network for Organ Sharing (UNOS) invented the first
computerized simulation of the liver allocation process, known as the UNOS Liver
Allocation Model (ULAM).Various medical prognosis (MP) models mainly based on
statistical data analytics modeling. Z. Qi et al. [13] describe in their paper how Polyvinyl
Alcohol (PVA) can be applied in Islet transplantation for Type-1 Diabetic patients though
there are not much research work done on the long-time successful rate of Survival of the
patient with very accurate MP models. A. K. Iyer et al. [14] presents a biologically based
discrete-event simulation model for liver transplantation. Their approach is a variant of
Alagoz, O., Bryce, C. L., Shechter et al. [15] model which is based on Empiric Natural
History Model. Alagoz, Oguzhan, et al. [16]. They address the problem of optimally
timing a living-donor liver transplant to maximize the patient's total reward, such as
quality-adjusted life expectancy. This approach is based on Markov Decision
Process(MDP). The drawback of this kind of reward-oriented modeling is very complex
to implement and as MP is hugely depends on patient’s historical data, so reinforcement
learning (RL) approach does not yields fruitful results. J. H. Fielder [17] describes a lot of
issues related to organ transplants. D. Medved, P. Nugues et al. [18] address the issue of
waiting time related to heart transplant. Through they discuss about 10 most significant
parameters predicting the patient status for the three different time points, but not explore
the survival of the patient in a long run. A. Ravikumar et al. [19] proposed a MP model of
renal transplantation using Support Vector Machine (SVM). Though they determine
10

survival critic factor using Cox regression model, but their approach lacks long term
survival analysis with more detail data and parameter. L. Al-Ebbini et al. [20] proposed a
hybrid technique to understand different parameters and predict the survival which they
termed as quality of life (QoL) for lung transplantation. Their approach mainly focused
on parameter ranking rather than survival analysis. C. G. Raji et al. [21] presents their
approach for survival of liver transplantation using multi-layer perceptron. Their
approach lacks speed in implementation as they not proposed and implemented their
approach in parallel mode.
2.2 Medical Prognosis System for Breast Cancer
There were two different types of work we had completed in this regard. The following
section will describe the literature review for each of the work which was completed
regarding Medical Prognosis System design for Breast Cancer.
2.2.1 Breast Cancer Dataset Analysis using Unsupervised Learning
The research work that was done by S. Muthukumaran et al.[22], Nepomuceno et
al.[23], Doruk Bozdag et al.[24] use Bi-clustering approach. V Sangeetha [25] et al.
investigate their research using genetic algorithm and Spiking Neural Networks to
generate cluster in their breast cancer dataset which are very prosing in this domain of
research. Their integration of genetic algorithm and Spiking Neural Network helps to
develop the prognosis system. T. Padhi [26] et al., D. Verma et al. [27] uses weka
Software tool to get the cluster for breast cancer dataset. L. M. Naeni et al. [28],
Taosheng Xu et al.[29] uses gene expression and biomarker to investigate gene
expression profiling to cluster the cancer dataset. A. L. Fijri et al. [30], P. H. S. Coutinho
et al. [31] describe in their paper some kinds of Fuzzy analysis to cluster the dataset. D.
11

Wu, L. Sheng et al. [32] and Chen D et al. [33] describe in their paper an ensemble
algorithm for clustering cancer data. This algorithm is based on the k-medoids or
partitioning around medoids (PAM) algorithm.
All this existing research mainly focus on predicting the class in known
perspective rather than investigation of the fundamental unsupervised mechanism to
segregate the datapoint in the dataset.
Investigation of the dataset in unsupervised way is very import in terms of designing
more accurate model for data labeling which further can be used by classification and
prediction problem.
2.2.2 Breast Cancer Prognosis Model Design
While had acquired the knowledge of breast cancer data analysis and implementing our
unsupervised clustering analysis which were presented in the previous section, now we
were thinking more holistically and try to develop the breast cancer prognosis model
using machine learning technique. We had observed that Medical specialists need to
depend on a host of pathology tests after initial biopsy. It takes a lot of time like weeks
and sometimes months before they decide whether they should go for lumpectomy
operation or mastectomy operation, or chemotherapy would be the better choice, or
radiotherapy, otherwise endocrine therapy needed or not which was fully depends on
their diagnosis and treatment and lot of clinical, pathological and recommender system
guidelines [34 -36]. Due to this there is potential research demands to automatically
identify and detect whether a patient’s tumor is malignant or benign with the help of
statistical machine learning model or ensemble learning model. Jafarpisheh, Nafisi and
Teshnehlab [37] describe a combination of machine learning approaches for breast
12

cancer. Naveen, Sharma and Ramachandran Nair [38] presents an ensemble machine
learning model. Amitha and Selvamani [39] provides a survey on automatic breast cancer
grading of histopathological images. They claim that computer-aided image analysis
systems can be used to automatically find their breast cancer grade. Imani, Chen, Tucker
and Yang [40] describes survival analysis of cancer recurrences based on random forest
modeling. Elnahas, Hussein and Keshk [41] proposed an ensemble technique using
artificial neural network to im-prove classification accuracy. Kumari and Krishna [42]
provides a survey of different machine learning model which are in used to design the
prognosis of the diseases. Zhu W, Xie L, Han J and Guo X [43] presents a comprehensive
review of cancer prognosis system by use of deep learning methods. B. Fu, P. Liu, J. Lin,
L. Deng, K. Hu and H. Zheng [44] describe an early-stage breast cancer prognosis model,
they named it as MP4Ei Framework. Huang S, Yang J, Fong S, Zhao Q [16] analyses in
their review work about research on the application of Artificial Intelligence (AI) to
cancer diagnosis and prognosis. They also give a brief discussion about the ad-vantages
of using AI in this field. H. Lu, H. Wang, S.W. Yoon [45] proposed a novel genetic
algorithm-based online gradient boosting (GAOGB) model for incremental breast cancer
(BC) prognosis where it has been adopted with Gradient Descent based loss minimization
and Generic Algorithm(GA) based parameter optimization schemes.
2.3 COVID-19 Prognosis Model Design
When the COVID-19 pandemic broke out we started gathering all sort of information
related to COVID-19 from all the sources available. We then started to collect the dataset
whichever available that time and later on increasing the size of the dataset as the
pandemic continues and cases increases day by day. The dataset we had collected
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consists of Chest X-Ray(CXR) image data and Chest Computed Tomography(CT) scan
image data.
The deep neural network model we work have divided into four research sections as in
each research direction we follow different kinds of methodology to build the COVID-19
prognosis model. So, the following section would describe the literature review which are
related to this four different kinds of research work related to COVID-19.
2.3.1 COVID-19 Prognosis Model Design using CXR
The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causes the
disease which was named by the scientist as COVID-19. This COVID-19 disease became
the most horrible pandemic in this current century. Initially, we gather the information
from World Health Organization(WHO), Center for Disease Control and Prevention,
other online news media and sources etc., [46–48]. Many reported source confirmed that
COVID-19 initially started in Wuhan City of China in December, 2019[46-48]. Research
suggests that Lung involvement is the crucial noticeable manifestation of the disease,
ranging from asymptomatic disease or mild pneumonia, to severe disease associated with
hypoxia, critical disease associated with shock, respiratory failure and multi-organ failure
or death[49]. At the very beginning of the pandemic, due to the lack of knowledge of the
virus genome, the detection of the disease was undeveloped. COVID-19 RT-PCR, a realtime reverse transcription polymerase chain reaction (RT-PCR) test, is a very efficient
discovery in the qualitative detection of nucleic acid from SARS-CoV-2 in upper and
lower respiratory specimens [50]. Still now RT-PCR is considered as the clinical public
health standard for the detection of COVID-19. Many emerging issues, still, remain in
COVID-19 detection domain. The RT-PCR sensitivity rate is 60–70%,which is not very
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much promising and the test is expensive [51]. There is another test also very popular
nowadays known as rapid antigen detection test, which takes less amount of time
compared to RT-PCR as RT-PCR is very time consuming but with this rapid antigen test
we can have the confirmation report within an hour, but the problem is that the sensitivity
of this test is very low i.e. 60.5% in average sample cases.[51]. It is also do not able to
show the severity of the disease and often confused with other Pneumonia variants. Not
capable to distinguish different variant of COVID-19 as well.
In terms of machine learning and artificial intelligence technique is concerns, two very
efficient detection methods of COVID-19 is gaining popularity hugely in the prognosis
research community. These two approaches uses chest X-ray (CXR) and chest CT-scan
[52-60]. Deep Learning methods have revolutionized the field of AI, and due to their
potential application in medical diagnosis and prognosis systems, millions of human lives
could be saved [61,62]. Radiographic images such as CXR are inexpensive and less time
consuming to produce results compared to other clinical or laboratory modalities. Being
COVID-19 positive is characterized primarily by patches of ground-glass opacity and
consolidations [58]. Therefore, the CXR dataset is useful to test algorithms for detecting
COVID-19 and other pulmonary disorders. Successful machine learning approaches
could allow for rapid evaluations of chest X-ray images and thus enable radiologists to
filter potential candidates in a time-effective manner [59,60]. Studies using deep neural
networks have shown the effectiveness of the method in the diagnosis of pneumonia [59].
Another study of deep artificial neural networks using 470,388 fully anonymized
institutional adult chest radiographs from three hospitals was able to detect abnormalities
from normal adult chest radiographs with a high positive predictive value of 94% [60]. In
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the latter study, the average reporting delay was reduced from 11.2 to 2.7 days for critical
imaging findings (p < 0.001) and from 7.6 to 4.1 days for urgent imaging findings (p <
0.001) in the simulation compared with historical data [60].
According to the Centers for Disease Control and Prevention (CDC) [63], the Delta
variant of the coronavirus (B.1.617.2) causes more infections and spreads faster than the
original SARS-CoV-2 strain. Currently, vaccines remain the best way to reduce the risk
of severe illness, hospitalization, and death from COVID-19. However, the CDC
cautioned that the effectiveness of the vaccines against new variants that may arise,
including the new coronavirus variant Omicron (B.1.1.529), is not clear at this point in
time [64].
Detection of COVID-19 using CXR has certain advantages over other methods. Because
of the multiple mutations of the virus and the emergence of newer variants such as the
Delta variant and the South African Omicron variant (B.1.1.529), there is an urgent need
for rapid and automatic detection of COVID-19 using CXR images. If an automated
AI/ML model is readily available to health professionals, it will be a substantial
improvement in the clinical management of the disease.
2.3.2 Ensemble Model design for COVID-19 Detection
After successfully completed our literature review to design COVID-19 prognosis model
design and published our work in a high impact Web of Science journal, then we focused
on designing an ensemble model for COVID-19 detection. While researching on deep
learning ensemble model design, we investigate many advanced deep neural network
model and then study in detail their architectural building blocks, framework and
implementation details.
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The convolutional neural network(CNN) has more potential in case of classification of
complex model design. It is most effectively used for different types of computational
problems as well as image classification problems. There are many applications that were
implemented in different research papers with the help of deep neural networks. Due to
the advancement of different deep neural networks, like ResNet18, ResNet50[65],
AlexNet[66], DenseNet[67], VGG16[68], etc., we can make a very sophisticated machine
learning model which can detect COVID-19 from CXR, CT images, sometimes a
combination of both. Previously, a hand-crafted feature generation technique is used
where the heuristic approach was used a lot. Prior to COVID-19, P. Rajpurkar et al.[69],
describe a model named as CheXNet where they use a deep neural network to classify 14
kinds of Pneumonia disease. Their model uses over 100,000 frontal view X-ray images
with 14 diseases to develop their model. It was a very promising research work that can
greatly influence the study of COVID-19 research using ML. L. Wang et al.[70] develop
a machine learning model, they name it as COVID-Net using 13,975 CXR images. They
had a total of 8,066 patient cases who have no pneumonia i.e. normal cases and 5,538
patient cases who have non-COVID19 pneumonia. They had only 266 COVID-19 patient
cases which makes their dataset have data imbalance issues. S. Minace et al.[71], develop
their model using 5000 Chest X-rays. They used the transfer learning technique to use the
pre-trained weights in their model. The main disadvantage of this kind of transfer
learning weight is that the original deep learning network did not actually use a medical
dataset, more especially the COVID-19 dataset, so the weights may lead to bias
prediction to some extent. A.I. Khan et al.[72], named their model as CoroNet which
consist of 310 normal images, 330 Pneumonia Bacterial, 327 Pneumonia Viral, and only
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284 COVID-19 sample images. Their research was done in early April 2020 and hence
their model was built with such a lower number of sample cases.
2.3.3 COVID-19 Detection using CT images
Most of the literature review we already had completed helped a lot when we were
designing the model using Chest Computed Tomography(CT) images only. Here we were
need to research on current development on CT image related studies.
H. Panwar et. al [73], used a combination of CXR and CT images. Their research work
showed that CT images were also very efficient for designing the model. Later on many
research work[74-78] came up as the pandemic progresses where they used CT images to
design their prognosis model. We research on what were the shortcomings of those
research work and in this regard we found out that EfficientNet[79] performs better than
other deep neural network on CT image dataset. EfficientNet is a very efficient highperformance convolutional neural network architecture and scaling method that
uniformly scales all dimensions of depth, width and resolution using a compound
coefficient. Where benchmark deep neural models arbitrarily scale these factors, the
EfficientNet scaling method uniformly scales network width, depth, and resolution with a
set of fixed scaling coefficients. The effectiveness of model scaling is based on the
baseline network which is playing a key role in high performance. The baseline network
builds up with a deep neural architecture search using the AutoML MNAS
framework[80], which optimizes both accuracy and efficiency.
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2.3.4 COVID-19 Detection using combination of Chest CT and CXR images
As we already gathered a lot of knowledge by developing our different work on COVID19, we now moved to think of optimizing the model more efficiently and focused on most
advanced deep neural network model that come up very recently. The transformer deep
neural network models had already proven architecture for the problem related to Natural
Language Processing (NLP). While investigating more on their application on different
domain we found out that they had great potential for image related application as well,
like object detection, segmentation, classification etc.[81-89]. They are generally called
as ‘Vision Transformer’. While reviewing on these Vision transformer research works,
we also investigated problems related to data imbalance issues. The research articles [9095], shows how data imbalance issues are very crucial while designing machine learning
models. The medical dataset, in many cases lacks positive sample cases and if we
designed the model with less number of positive samples compared to the bigger number
of negative samples then due to data imbalance the weightage values for detection
became faulty and do not perform well on test dataset or unknown dataset.
Then we implemented our model using vision transformer, then we extend our research
review more on the very recent advancement of this field, especially in the image
detection and classification of challenging dataset. Then we study and try to develop our
own classification model using “A ConvNet for the 2020s”[96]. Which is the most recent
research in this area where advance ResNet and CNN was used.
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CHAPTER III - SURVIVAL PREDICTION MODEL FOR RENAL
TRANSPLANTATION

Our in this published research work[97], we mainly focused on how to speed up
the deep neural network. We used parallelizing in every stage of the development of our
parallel implementation model. Automated recommender system designed by artificial
intelligence and machine learning method saves lot of time as it is very efficient and easy
to implement. It not only improves the medical system but saves a lot of human life.
Medical prognosis has become an emerging area in health care research where several
reliable prognostic models based on survival analysis procedures have been useful to a
variety of domains, with different degrees of success [98]. With the invent of new
bioinformatics technology and medical engineering the success of organ transplantation
model and survival improve a lot. In this paper, an effective and accurate Parallel Phase
Neural network model (PHNNM) has been proposed for the prediction of the long-term
survival of liver patients who undergo liver transplantation (LT). Any medical prognosis
system needs a lot of data analytics systems and historical observational data from
medical hospitals and research laboratories. Efficient and accurate medical prognosis
systems is always in demand but most of the current systems rely on serial
implementations which lacks performance and speeds.
3.1 Methodology
A. Data Source
Our dataset was collected from Scientific Registry of Transplant Recipients(SRTR), USA
which collected the data from United Network for Organ Sharing (UNOS) registry, USA.
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B. Data Preprocessing and final Data Description
After receiving the dataset, a whole lot of preprocessing need to be done to use for a data
analytics model. We first corrected the missing values and adjusted the outlier’s data. The
continuous features are transformed using the MaxMinScaler(), the numerical features
are scaled by z-score normalization and the categorial features are transformed using
One-hot encoding to scale to the range [0, 1]. Keep in mind that now both our categorical
features, numerical features and continuous features are all in the range [0, 1]. Then we’ll
concatenate categorical features, numerical features with continuous features using
Python’s NumPy’s hstack function. Then the data is then split into training and test data.
The final data consists of the following things,
1) The total number of instances used = 8272
2) The total number of attributes used = 61
There are 29 categorical attribute and 10 numerical attribute, 22 continuous attribute was
used in this research work.
These are as follows,
i)

Categorial: 29 ('DON_GENDER', 'DON_RACE_SRTR',
'DON_ETHNICITY_SRTR', 'DON_ABO', 'DON_ANTI_CMV',
'DON_ANTI_HCV', 'DON_INOTROP_AGENT_GE3',
'DON_NON_HR_BEAT', 'CAN_GENDER', 'CAN_RACE_SRTR',
'CAN_ETHNICITY_SRTR', 'CAN_ABO', 'REC_TX_EXTRA_VESSEL',
'REC_CMV_IGG', 'REC_CMV_IGM', 'REC_CMV_STAT',
'REC_HBV_ANTIBODY', 'REC_HBV_SURF_ANTIGEN',
'REC_HCV_STAT', 'REC_LIFE_SUPPORT', 'REC_PORTAL_VEIN',
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'REC_TIPSS', 'CAN_DRUG_TREAT_HYPERTEN',
'CAN_PERIPH_VASC', 'CAN_DRUG_TREAT_COPD',
'CAN_PULM_EMBOL', 'CAN_BACTERIA_PERIT',
'CAN_PORTAL_VEIN', 'CAN_TIPSS')
ii)

Numerical: 10 ('TARGET_VALUE', 'DON_HGT_CM', 'DON_WGT_KG',
'DON_CREAT', 'DON_SGOT', 'REC_HGT_CM', 'REC_WGT_KG',
'REC_BMI', 'CAN_HGT_CM', 'CAN_WGT_KG')

iii)

Continuous: 22 ('DON_AGE', 'DON_HIST_DIAB',
'DON_HIST_HYPERTEN', 'DON_A1', 'DON_A2', 'DON_B1', 'DON_B2',
'DON_DR1', 'DON_DR2', 'DON_HIGH_CREAT', 'DON_HTN',
'DON_COD_DON_STROKE', 'REC_DGN', 'DON_ORG_SHARED',
'REC_VENTILATOR', 'REC_LIFE_SUPPORT_OTHER', 'REC_DGN2',
'REC_AGE_AT_TX', 'CAN_DGN', 'CAN_DIAB_TY',
'CAN_AGE_AT_LISTING', 'CAN_PREV_LI')

iv)

As we eliminate all missing attribute values so there is no missing value for
attribute we fed to the system.
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Figure 3.1 Block Diagram of Proposed Approach
C. Model Description
Keras[99] is an Application Programming Interface(API) mainly used for designing
neural network. The model runs on top of TensorFlow In this paper, a neural network is
built in Keras to solve the regression issue, i.e. one where our dependent variable
,Survival of the patient(y) is in numerical format and we are trying to predict the quantity
of y with as much accuracy as possible. We done Random forest regression analysis. We
train the neural network using the 135 input variables, along with 4 hidden layers of 32,
16, 8 and 4 neurons respectively, and finally using the linear activation function to
process the output. Here this paper uses Mean Squared Error (MSE) and Mean Absolute
Error (MAE) as our loss functions. Validation split set to 0.2, that is 80% training data
and 20% test data. We have specified 200 epochs for our model. This means that we are
essentially training our model over 200 forward and backward passes, with the
expectation that our loss will decrease with each epoch, meaning that our model is
predicting the value of y more accurately as we continue to train the model. parallel
implementation of our model using CUDA also introduced in our implementation[100].
23

3.2 Results
Both the training and validation loss decrease in an exponential fashion as the number of
epochs is increased, suggesting that the model gains a high degree of accuracy as our
epochs is increased and then reached the saturation point.
A. Serial Implementation Result
Table 3.1 Serial Performance
Mean
Mean
Squared
Absolute
Error(MSE) Error(MAE)
12.62
2.71

Test
Variance
Value
0.11

Figure 3.2 Training and Validation Loss over increasing epoch.

B. Serial result using Random Forest Regression
Random Forest Regressors(RFR) is the way for splitting criterion to measure the
quality of a split. Supported criteria are “MSE” for the mean squared error, which
is equal to variance reduction as feature selection criterion, and “Mean Absolute
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Error” for the mean absolute error. We have applied same parameter for random
forest regressor.
Table 3.2 Random Forest Result
Coefficient of determination
R2 of the prediction

Mean Squared
Error(MSE)

0.8693909563710034

0.02

Test Variance
value

0.06

C. Parallel implementation Result
The computational time improves a lot in parallel implementation, through MSE and
MAE nearly same with the serial implementation.
Table 3.3 Illustrate Runtime with Different Batch Size and epoch
No. of
Epoch

50

No.
of
CPU
Core
1
4
8
12
16
20

200

1
4
8
12

Runtime
Batch Batch Size
Size
=32
= 16
74.09 42.022
8
72.27 38.715
0
71.27 38.154
6
71.18 38.768
4
70.68 37.587
6
70.49 37.580
8
716.0 376.748
48
705.5 370.102
25
703.6 367.999
25
697.4 366.161
47

Batch Size
=64

Batch Size
=128

Batch
Size=256

23.251

15.090

10.059

22.787

13.490

10.013

21.932

13.435

9.641

21.795

13.417

9.450

21.269

12.932

9.290

20.999

12.814

9.184

205.262

124.256

85.568

198.557

122.077

82.892

197.342

118.512

82.779

195.877

117.644

77.748

25

16
20
500

1
4
8
12
16
20

696.6
82
692.7
42
716.0
48
705.5
25
703.6
25
697.4
47
696.6
82
692.7
42

364.096

195.787

114.996

77.399

361.660

194.612

114.445

73.100

376.748

205.262

124.256

85.568

370.102

198.557

122.077

82.892

367.999

197.342

118.512

82.779

366.161

195.877

117.644

77.748

364.096

195.787

114.996

77.399

61.660

194.612

114.445

73.100

Figure 3.3 Runtime over Epoch = 50 with different batch sizes
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Figure 3.4 Runtime over Epoch = 200 with different batch sizes.

Figure 3.5 Runtime over Epoch = 500 with different batch sizes
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The above figures, 3.5, 3.6, 3.7 illustrate how runtime decreases over the increase of
batch size as well as increase of number of epochs. These show the inversely proportional
relationship as we increase batch size the runtime decreases. At higher values of CPU, we
received an approximate 2x decrease in computation time. This is what we expected, as
we were spreading the work over 20 cores.

Table 3.4 Illustrates Speedup with batch size and epochs
Speedup
#Epoch #CPU
Batch Size = 16 Batch Size = 32

50

200

500

Batch Size = 64

Batch Size =
128

Batch Size =
256

2

1.018872531

1.085209345

1.003374684 1.103234533 1.002865208

4

1.02528877

1.085413561

1.020361035 1.118619812 1.004560947

8

1.039585507

1.101388052

1.060166207 1.123239456 1.043324605

12

1.040931751

1.112649311

1.066792729 1.124698449 1.058879504

16

1.048264296

1.118003005

1.093202151 1.166864258 1.082835449

20

1.051063833

1.11820142

1.107243846 1.177675261 1.095267443

2

1.034900764

1.012438642

1.002435047 1.015201915 1.252254939

4

1.038565488

1.012529357

1.004807716 1.022954555 1.329733023

8

1.039412193

1.014973298

1.015902556 1.032491296 1.364403162

12

1.041884447

1.021144269

1.025328093 1.033360859 1.37813022

16

1.059586139

1.043212523

1.029110537 1.040007666 1.397060562

20

1.059803539

1.04350392

1.043024557 1.073935364 1.430054563

2

1.009392495

1.013562475

1.007332236 1.016686305 1.011191557

4

1.014914844

1.017957405

1.033769142 1.017843871 1.032286682

8

1.017655584

1.023773591

1.040136045 1.048462678 1.033693981

12

1.026670401

1.028914117

1.047915642 1.056204112 1.10058289

16

1.027796694

1.034749502

1.048394931 1.080526567 1.105545257

20

1.033643117

1.041720056

1.054728064 1.085719938 1.170564799
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Figure 3.6 The speedup/scalability over different batch sizes and epochs.
Figure 17 shows the scalability of our proposed parallelism technique on CPU algorithm.
Based on the result we see that speedup is increasing with the increase of number of
processing elements. This technique is validated on several number of epochs and the
effect of the increasing in speedup is envisioned similarly that proves that the system is
scalable. In case of epoch 200, the performance doesn’t make so differences except Batch
size = 256.

Table 3.5 Illustrates efficiency over different batch sizes and epochs
Efficiency
#Epoch #CPU

50

200

Batch Size = 16

Batch Size = 32

Batch Size = 64

Batch Size = 128

Batch Size = 256

2

0.509436266

0.542604673

0.501687342

0.551617267

0.501432604

4

0.256322193

0.27135339

0.255090259

0.279654953

0.251140237

8

0.129948188

0.137673507

0.132520776

0.140404932

0.130415576

12

0.086744313

0.092720776

0.088899394

0.093724871

0.088239959

16

0.065516519

0.069875188

0.068325134

0.072929016

0.067677216

20

0.052553192

0.055910071

0.055362192

0.058883763

0.054763372

2

0.517450382

0.506219321

0.501217523

0.507600958

0.62612747

4

0.259641372

0.253132339

0.251201929

0.255738639

0.332433256

8

0.129926524

0.126871662

0.12698782

0.129061412

0.170550395

29

500

12

0.086823704

0.085095356

0.085444008

0.086113405

0.114844185

16

0.066224134

0.065200783

0.064319409

0.065000479

0.087316285

20

0.052990177

0.052175196

0.052151228

0.053696768

0.071502728

2

0.509436266

0.542604673

0.501687342

0.551617267

0.501432604

4

0.256322193

0.27135339

0.255090259

0.279654953

0.251140237

8

0.129948188

0.137673507

0.132520776

0.140404932

0.130415576

12

0.086744313

0.092720776

0.088899394

0.093724871

0.088239959

16

0.065516519

0.069875188

0.068325134

0.072929016

0.067677216

20

0.052553192

0.055910071

0.055362192

0.058883763

0.054763372

Figure 3.7 Illustrates the efficiency with increase batch size and epochs.
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CHAPTER IV - MEDICAL PROGNOSIS SYSTEM FOR BREAST CANCER

This chapter will describe our work related to medical prognosis. Initially, we tried to
investigate the dataset with different clustering techniques which fall under the
unsupervised machine learning methodology. Then we developed the full-fledged
medical prognosis system for breast cancer. The research works presented in [101,102]
are divided into two portions, one is clustering analysis and another one is the medical
prognosis system design. The following sections will describe both the approaches.

4.1 Unsupervised learning exploration using breast cancer dataset
Cancer is a group of diseases involving abnormal cell growth with the potential to
invade or spread to other parts of the body.
According to US Federal Government’s principal agency, The National Cancer
Institute (NCI), Cancer is the name given to a collection of related diseases. In all types
of cancer, some of the body’s cells begin to divide without stopping and spread into
surrounding tissues.
Cancer is the second leading cause of death in the United States, exceeded only by heart
disease. One of every four deaths in the United States is due to cancer.
Breast cancer is one of the major kinds of cancer that develops from breast tissue.
Signs of breast cancer may include a lump in the breast, a change in breast shape,
dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or
scaly patch of skin.
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According to the US’s leading national public health institute Centers for Disease Control
and Prevention (CDC), Breast cancer is the second most common cancer among women
in the United States.
Clustering techniques can generally be divided into two areas, one is hard
clustering where the dataset can be clearly divided into two or more parts. We have a
clear viewpoint whether a data point belongs to a particular cluster or not. For soft
clustering, instead of setting each data point into a distinct cluster, a probability or
likelihood of that data point to be in those clusters is given.
4.1.1 Methodology
A. Dataset Description and Pre-Processing
Table 4.1 Details of Attributes of Breast Cancer Data
No. of Attributes
1. Sample code number
2. Clump Thickness
3. Uniformity of Cell Size
4. Uniformity of Cell Shape
5. Marginal Adhesion
6.Single Epithelial Cell Size

Domain
Id Number
1-10
1-10
1-10
1-10
1-10

7.Bare Nuclei
8. Bland Chromatin
9.Normal Nucleoli
10. Mitoses
11. Class

1-10
1-10
1-10
1-10
2 for benign, 4 for malignant

We preprocess the data using normal preprocessing techniques like eliminating the null
values, using soft-encoding we set the parameter values within the range of 1-10 etc.
The data is downloaded in .csv format. In the csv extension, we delete all the 16 rows that
had the missing values. After that the csv extension was converted to a Weka friendly file
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which is Attribute Relation Data Format (ARFF)extension. Then the data goes through a
series of preprocessing steps.
No. of Instances in the dataset before Preprocessing = 699
No. of Instances in the dataset after Preprocessing = 683
Then we use Weka software to further normalize the dataset using min-max
normalization method so that all the feature values are in [0, 1]. Clustering is an
unsupervised learning method, so only feature values are used for clustering. This means
we do not normalize the category label which is the last column in the dataset.
First, we remove the ID number. Then we use Weka to further preprocess the
dataset. Then we investigate the dataset to understand correlation among the datapoints
using Hopkins Statistic Index to understand whether the dataset has good clustering
tendency or not. Then we perform different sort of clustering technique both using Weka
Software Tools and R programing language.

4.1.2 Results
In our Breast Cancer data, we got Hopkins Statistic Index = 0.7997314 which indicates
the dataset is highly clustered.
K-means Clustering Analysis Results:
Table 4.2 Cluster Instances after K-means
Cluster Instances
Benign

402

59%

Malignant

281

41%
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Figure 4.1 K-means cluster visualization

Figure 4.2 Box plot clearly illustrate the dataset has two optimal clusters.

Figure 4.3 K-means clustering with varying parameter values
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Figure 4.4 K-means for different values of k

K-medoids clustering or Partitioning Around Medoids (PAM) results:
An alternative to k-means clustering is the K-medoids clustering or Partitioning Around
Medoids(PAM) [103], which is less sensitive to outliers compared to k-means clustering
methods.

Figure 4.5 K-medoids clustering or Partitioning Around Medoids(PAM)
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Silhouette Analysis Using R on Breast Cancer Dataset:
Silhouette analysis allows you to calculate how similar each observation is with the
cluster it is assigned relative to other clusters. This metric (silhouette width) ranges from
-1 to 1 for each observation in your data and can be interpreted as follows:
i)

Values close to 1 suggest that the observation is well matched to the
assigned cluster.

ii)

Values close to 0 suggest that the observation is borderline matched
between two clusters.

iii)

Values close to -1 suggest that the observations may be assigned to the
wrong cluster.

In our research we got the metric (silhouette width) value = 0.57 which clearly shows that
the Breast Cancer Dataset well matched to the assigned cluster.

Figure 4.6 Silhouette Plot of K-medoids or PAM
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Figure 4.7 Average Silhouette Score plot of K-means clustering.
Average Silhouette Score plot of K-means clustering where K varies from 2 to 10 and the
Highest Silhouette value is 0.582 which shows that the Breast Cancer Dataset well
matched to the assigned cluster, when cluster size =2.

4.2 Medical Prognosis System Design for Breast Cancer
This section would elaborate the work[102] for designing medical prognosis system
design for breast cancer.
4.2.1 Methodology
Weka Software tool
Waikato Environment for Knowledge Analysis (Weka), developed at the
University of Waikato, New Zealand. It is free software licensed under the GNU General
Public License, and the companion software to the book "Data Mining: Practical Machine
Learning Tools and Techniques". It is mainly used for Machine learning, Data Analysis
and Data Visualization purposes.
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The Weka version that is used in analyzing this breast cancer data and predict whether a
patient has breast cancer or not is 3.8.4. The following discussions shows how the
methods was used in Weka.
We use the same dataset by which we work for clustering technique, so this section will
not describe again the dataset and preprocessing part also the clustering technique, rather
in this section will describe more about supervised methods and the whole process of
designing the model. The different classification methodologies we have used are as
follows,
A. Random Forest(RF)
One of the most interesting supervised learning technique is the Random Forest[104]. It
actually leverage the power of decision trees and it ensembles multiple decision tress and
chose the optimum value for decision making. It also unlock the potential of bagging
method which also combine multiple learning methods to optimize the overall results.
Random forest essentially constructs a number of decision trees and merges them to get a
more accurate, robust and balanced prediction. The parameters used in the random forest
method in Weka are:
i.

The size of each bag. (i.e., P)

ii.

Calculate the out of error bag. (i.e., O)

iii.

Number of iterations or number of trees in random forest. (i.e., I)

iv.

Minimum number of instances. (i.e., M)

v.

Minimum variance of split. (i.e., V)

vi.

Seed for random number generator. (i.e., S)

vii.

Depth of the tree.
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Figure 4.8 Weka interface for parameter tuning for Random Forest(RF)
B. Support Vector Machine(SVM)
Support Vector Machine(SVM)[104], is a very powerful and widely used supervised
learning technique where the algorithm try to find a hyperplane in an N dimensional
space. Here N is the total number of the features used in that specific dataset. Hence, in
this approach SVM able to distinctly segregate the datapoints, most of the cases very
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successfully. SVM can perform well on linear classification problems as well as nonlinear classification problem. The Kernel function that was used in Weka for our dataset
is Radial Basis Function(RBF). RBF mostly used Euclidian Distance most of the cases to
calculate the distance of the datapoint to the hyperplane where mostly source or center of
the datapoint is considered.

Figure 4.9 Weka interface for Support vector Machine(SVM)
C. Multi-layer perceptron(MLP)
Multilayer perceptron is a deep artificial neural network, and it is composed of more than
one perceptron. They are made of an input layer, one or more hidden layers and an output
layer that makes a prediction about the input. Each layer is made up of units. The input to
the network corresponds to the attributes measured for each training tuple. Multilayer
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perceptron is often applied to supervised learning problems. Fig. 4.2.1. shows the
multilayer feedforward neural network for our Breast Cancer Dataset. The input layer
consists of 10 attributes values, 2 hidden layers, 1st hidden layer having 4 nodes and 2nd
hidden layer having 6 nodes and output layer have 2 nodes for 2 class, 2 for benign and 4
for malignant. We also heuristically change the number of hidden layers and other
parameters to get the optimum parameter settings.

Figure 4.10 Weka interface for multi-layer perceptron
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Figure 4.11 Multilayer Feedforward Neural Network for our Breast Cancer Dataset.
The following are some of the parameters that was used in Weka on our dataset.
i. Learning rate. (i.e., L)
ii. Momentum rate. (i.e., M)
iii. Number of epochs.(i.e., N)
iv. Percentage size of validation set.(i.e., V)
v. The value use to seed the random number generator. (i.e., S)
vi. The number of consecutive increases of error allowed for
validation testing before training terminates.(i.e., E)
The system also performs cross-validation and parameter optimization.

D. C4.5 Algorithm or J48
C4.5 is a specialized decision tree classifier in the domain of supervised learning
algorithms which are mostly used in data mining domain and have a huge potential to use
decision tree algorithms to make proper classification decisions.
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C4.5 was invented by J.R. Quinlan[105] in 1993. Then onwards it was used in many
domains of decision making problem solving and classification tasks. J48 is named
coined for open-source Java implementation of C4.5 algorithm in Weka machine learning
tool. The following figure 4.2.2 shows the classification in Weka system using J48
algorithm.
4.2.2 Results
The results were very promising for this work. This work received best paper award in an
International Conference held in 2021.
After heuristically run-through many types of cross validation the optimum value settle
with 10 fold cross-validation. The following table shows the results with all the
techniques discussed above.

Figure 4.12 Generating Decision Tree using J48 for Breast cancer dataset
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Table 4.3 Comparing All Methods using 10-Fold Cross Validation.
Random Forest
(RF)

Support Vector
Machine
(SVM)

Multi-Layer Perceptron
(MLP)

J48

Correctly
Classified
Instances

97.2182 %

96.4861 %

96.0469 %

93.4114%

Incorrectly
Classified
Instances

2.7818 %

3.5139 %

3.9531 %

6.5886 %

Kappa Statistics

0.939

0.9241

0.914

0.8564

Mean Absolute
Error

0.064

0.0351

0.0404

0.1008

Root Mean
square error

0.1615

0.1875

0.179

0.2384

Relative
Absolute Error

14.0555 %

7.7211 %

8.8702 %

22.1551 %

Root Relative
Square Error

33.8557 %

39.3026 %

37.5253 %

49.9826 %

Total Number
of Instances

683

683

683

683

The results showing in the table clearly prove that Random Forest(RF) performs better
for our breast cancer dataset. then Support Vector Machine, Multi-layer Perceptron(MLP)
and J48 values are rank respectively. The automated ensemble breast cancer prognosis
model provides the optimum value for any kinds of test dataset.

a) Results for Random Forest(RF) classifier
After running our data through Weka, the following table and figures were the outputs we
got. Table 2 gives the confusion matrix of the 137 instance that was used to test the
model. It shows clearly that our model was able to correctly predict 99 instances to be
benign out of 102 which were benign. It was able to predict 33 patients who were
malignant out of the 35 who were malignant. From Figure 6, 98% of the tuples was
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labeled positive by our classifier out of the actual positive (i.e. precision), 97.1% of the
positive tuples is the percentage our classifier labeled as positive (i.e. recall), the
harmonic mean of precision and recall is 0.975 (i.e. F-measure). This value is very close
to 1 which means the models accuracy is better. Again, in Figure 6, the true positive
recognition rate is 0.971 (i.e. Sensitivity=TP/P) and the true negative recognition rate is
0.943 (i.e. Specificity=TN/N). Figure 8 and 9 shows the ROC curves for benign (2) and
Malignant (4) respectively, the Area Under these Curves i.e. AUROCs, are 0.992. This
means our model has almost a perfect accuracy because is close to 1.
Table 4.4 Confusion Matrix for Random Forest(RF)
Actual\Predicted
Benign
Malignant
Total

Benign
99
2
101

Malignant
3
33
36

Figure 4.13 Weka output figure for Random forest
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Total
102
35
137

Figure 4.14 Receiver Operating Characteristic curve(ROC) using RF for class 2

Figure 4.15 Receiver Operating Characteristic curve(ROC) using RF for class 4
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b) Results for SVM Classifier
When we did run our data through Weka, the following table and figures were the outputs
we got. Table 3 gives the confusion matrix of the 137 instance that was used to test the
model. It shows vividly that our model was able to correctly predict 97 instances to be
benign out of 102 which were benign. It was able to predict 34 patients who were
malignant out of the 35 who were malignant. From Figure 9, 99% of the tuples was
labeled positive by our classifier out of the actual positive (i.e. precision), 95.1% of the
positive tuples is the percentage our classifier labeled as positive (i.e. recall), the
harmonic mean of precision and recall is 0.97 (i.e. F-measure). This value is very close to
1 which means the models accuracy is better. Figure 9, the true positive recognition rate
is 0.951 (i.e. Sensitivity=TP/P) and the true negative recognition rate is 0.971 (i.e.
Specificity=TN/N). Figure 4.2.9 and Figure 4.2.10 exhibits the ROC curves for benign
(2) and Malignant (4) respectively, the area under these curves (i.e. AUROCs) are 0.961.
This means our model has a better accuracy because is close to 1.

Table 4.5 Confusion Matrix for SVM
Actual\Predicted
Benign
Malignant
Total

Benign
97
1
98

Malignant
5
34
39
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Total
102
35
137

Figure 4.16 Weka output figure for SVM

Figure 4.17 Receiver Operating Characteristic curve(ROC) using SVM for class 2
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Figure 4.18 Receiver Operating Characteristic curve(ROC) using SVM for class 4

c) Results for Multilayer Perceptron (MLP)
Preprocessed breast cancer data set was run through Weka, the following table and
figures were the outputs we got. Table 4 gives the confusion matrix of the 137 instances
that was used to test the model. It shows that our model was able to correctly predict 99
instances to be benign out of 102 which were benign. It was able to predict 34 patients
who were malignant out of the 35 who were malignant. In Figure 12, 99% of the tuples
was labeled positive by our classifier out of the actual positive (i.e. precision), 97.1% of
the positive tuples is the percentage our classifier labeled as positive (i.e. recall), the
harmonic mean of precision and recall is 0.98 (i.e. F-measure). This value is very close to
1 which means the models accuracy is better. Figure 12, the true positive recognition rate
is 0.971 (i.e. Sensitivity=TP/P) and the true negative recognition rate is 0.971 (i.e.
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Specificity=TN/N). Figure 13 and 14 shows the Roc curves for benign (2) and Malignant
(4) respectively, the area under these curves (i.e. AUROCs) are 0.995. This means our
model has almost a perfect accuracy because is close to 1.

Table 4.6 Confusion Matrix for MLP
Actual\Predicted
Benign
Malignant
Total

Benign
99
1
100

Malignant
3
34
37

Figure 4.19 Weka output figure for MLP

50

Total
102
35
137

Figure 4.20 Receiver Operating Characteristic curve(ROC) using MLP for class 2

Figure 4.21 Receiver Operating Characteristic curve(ROC) using MLP for class 4
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CHAPTER V – COVID-19 PROGNOSIS MODEL DESIGN

In this section we would describe about our works related to COVID-19 prognosis
model design. Initially we started our work from the very beginning of the pandemic.
After gathering most of the research information, dataset and implementation
methodologies, we had successfully published one high impact journal article and two in
the international conference. The most recent work is yet to be published.

5.1 COVID-19 Prognosis Model Design using Chest X-Ray images
In this research work, we had developed a Deep Learning Method (DLM) to detect
COVID-19 using chest X-ray (CXR) images. Radiographic images are instantly
accessible and can be used efficiently for COVID-19 detection contrasted to other costly
and slow pathological tests. We used a dataset of 10,040 samples, of which 2143 had
COVID-19, 3674 had pneumonia (but not COVID-19), and 4223 were normal (no
COVID-19 or pneumonia). Our model had a detection accuracy of 96.43% and a
sensitivity of 93.68%. The area under the ROC curve was 99% for COVID-19, 97% for
pneumonia (but not COVID-19 positive), and 98% for normal cases. In conclusion, ML
approaches may be used for rapid analysis of CXR images and thus enable radiologists to
filter potential candidates in a time-effective manner to detect COVID-19.

5.1.1 Methodology
A. Dataset Development and Preprocessing
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The dataset collection started from the mid of April as some open source platform
including Github, Kaggle etc.[106-109] provide the Chest X-Ray(CXR) images of the
COVID-19 positive patients. COVID-19 is kind of a complex pneumonia so we try to
think of if other kinds of pneumonia detection can easily possible through chest X-Ray
images then if we have enough number of COVID-19 positive CXR then we could
develop the deep learning model for the design of the prognosis system.
The dataset has three types of image files,
i.

CXR images of COVID-19 infected patients

ii.

CXR images of patients with pneumonia other than COVID-19

iii.

CXR images of normal human

Figure 5.1 Three categories of Chest X-Ray(CXR) images
This figures shows three categories of the images that we have collected. We make
training dataset, validation dataset and test dataset. Though there are some patches
visually seen to identify and detect COVID-19 but it could result to human error. When
we pass this images though a deep learning prognosis system model, it undergoes deep
layers in the neural network which feature engineering the underlining characteristic
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which are not visually seen by human eye and can more efficiently make more accurate
detection from different kinds of CXR images.

Figure 5.2 A Block Diagram Representation of the Deep Learning Model (DML)
The overall methodology is illustrated in this Figure 5.2 The steps of our procedure that
we had followed are mention as follows,
i.

First we collected the CXR dataset from open source repositories from the
internet.

ii.

Pre-process those images using different preprocessing technique like, deleting
unlabeled images, histogram normalization etc.

iii.

Segment the lung contour of the images needs pulmonary contour
masks[110,111] and efficient segmentation algorithm which can use those masks
to segment the segmented lung from the images. Here we use FC-DenseNet103
semantic segmentation algorithm[112] for the segmentation purpose.
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iv.

For designing the deep neural network model, there are basically two main
section of deep layers, the first part is known as feature generation layer, where
we use ResNet18 pretrained weightages to speed up the training process and
leverage the transfer learning technique. The second part is the classification
section where we design the layers according to multi-class classification
requirements for our dataset.

v.

Then the multi-class classification layer classifies the images into three sections,
COVID-19, Pneumonia and normal classes.

Figure 5.3 The Architecture of proposed Deep Learning Model (DML)
The Figure 5.3 illustrate the architecture of the proposed Deep Learning Model(DML),
which consist of 46 layers, out of which, 14 convolution layers, 23 hidden layers, 4 maxpooling layers, 2 average pooling layers, 2 dropout layers, and one SoftMax layer. In this
research work, we utilize the trained weightages of ResNet18 deep learning model
architecture which was trained on ImageNet[113], that is the benchmark standard for
deep learning community as it is the biggest variety of image dataset and the total number
of image is 3.2 million which makes the deep learning architecture more robustness. As
55

ResNet18 already trained on this gigantic dataset, so when our model used the
weightages it saves a lot of training time and complexity become more simpler. The
transfer learning of the feature deep layer framework is very helpful and currently widely
used standard in research community. After the feature generation architecture is
completed, we just need the classification layer to classify the images accordingly.

5.1.2 Results

The terminology used to evaluate the results is given in the Figure 5.1.4.

Figure 5.4 Terminology used to evaluate the performance of classification

56

Table 5.1 COVID-19 dataset details
Data
Before
Preprocessing
After
Preprocessing

COVID-19
2143

Pneumonia

Normal

Total

3674

4223

10040

3535

6072

6967

16574

The dataset that we had used to design our deep learning model is very well balanced and
collection of large sample data size. The total number of sample is 10,040. Out of which
2143 had COVID-19, 3674 had pneumonia and 4223 were normal patients data. We used
PyTorch's[114] augmentation library. The performed operations include horizontal,
vertical and rotational flips operation. By using this augmentation processes the image
sample size was increased by 65%.
After the augmentation procedure was completed, we used 80 % data sample for training,
20 % data sample for testing. 10 % data were used for validation purpose.

Figure 5.5 The Confusion matrix and Receiver Operating Characteristic(ROC) curve
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Figure 5.5 illustrate the confusion matrix and Receiver Operating Characteristic(ROC)
curve for our proposed Deep Learning Prognosis model. From the confusion matrix it is
very much evident that 3535 COVID-19 cases, 3520 were correctly detected, 12 images
were detected as normal cases, and 3 as pneumonia cases. Out of 6967 normal cases,
6893 were detected correctly, 21 were detected as COVID-19, and 53 were detected as
pneumonia. Moreover, out of 6062 pneumonia cases, 6017 were detected correctly, but
24 were detected as COVID-19 and 31 as normal cases. The Receiver Operating
Characteristic(ROC) curve clearly shows the high prediction accuracy of our model.

5.2 Ensemble Deep Learning Model design for COVID-19 Detection
This section would describe about the ensemble model that we had designed for
the detection of COVID-19. Ensemble models help to get the better accuracy as it
decreases the chance of getting errors from a single model, rather it optimizes the
parameter values which helps the model to be more efficient and accurate. It also helps to
avoid overfitting hence ensures higher consistency. Ensemble model also ensure all the
local bias is optimize and variance values are neutral to the model. This Ensemble deep
learning model provides accuracy of 93.56% and a sensitivity of 91.24% and an F1 score
was 0.91.
5.2.1 Methodology
As we already collected the data and performed data pre-processing operations
and augmentation operation, here in this work we used the same dataset with little bit of
modification. In this model we used a dataset of 6641 samples, of which 1684 had
COVID-19, 1845 had pneumonia, and 3112 were healthy individuals.
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Figure 5.6 A Block Diagram Representation of the Ensemble Deep Learning Model
From the figure 5.6 the procedure that we have followed in designing this model
is described as follows,
i.

Image data samples were collected

ii.

Image data samples were preproceed

iii.

Segmentation is perform to separate out the lung contour of the images. Here we
used a medical image segmentation algorithm, named as U-Net[115] which is
widely used for medical image segmentation purposes.

iv.

Then the segmented images were fed to ensemble network for classification.

Here in this ensemble model also used for classifying there kinds of images. One the
COVID-19 positive cases, another is other kinds of Pneumonia and the rest is healthy
patient data.
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Figure 5.7 Illustration of different deep learning model used for proposed EML model

5.2.2 Results
The proposed Ensemble Machine Learning(EML) model had an average detection
accuracy of 93.56% and a sensitivity of 91.24% and the F1 score is 0.91. Figure 4 shows
the loss curve which is clearly evident the loss decreases and Figure 5 shows the Test and
Train accuracy. The Train Accuracy is 97% and Test Accuracy is 92%.

Figure 5.8 Training loss vs Epoch
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Figure 5.9

Train and Test Accuracy

The Figure 5.8 illustrate the training loss vs epoch. As it shows after 10 epoch it
converges. Figure 5.9 illustrate the train and test accuracy of the model.

5.3 COVID-19 Prognosis Model Design using Chest CT images
This section will describe our work on COVID-19 prognosis model design using
Chest CT images.
5.3.1 Methodology

Figure 5.10 Chest CT images after preprocessing
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Our proposed model used a dataset of 8054 real patient CT scans, of which 5427
had COVID-19 and 4223 were Non-COVID-19 patient images. The dataset is further
divided into train, validation, and test sets with the ratio of 7:2:1. Figure 5.10 shows the
chest CT images after preprocessing.

Figure 5.11 Functional block diagram of the proposed Deep Learning approach
Figure 5.11 illustrates the functional steps that are followed for the design of the
COVID-19 prognosis system using Chest CT images only. The data collection, data
preprocessing and augmentation is similar to our previous two implementation but here
we use chest CT image and very efficient deep learning architecture, named as
EfficientNet[116], a pretrained Model, for the feature generation tasks. Then we added a
deep classification layer to classify the CT images into COVID-19 position images and
COVID-19 negative images, i.e. Non-COVID-19 images. After execution of the feature
generation tasks, the total number of parameters of our dataset is 18,830,011, out of
which Trainable params are 1,281,395 and Non-trainable params are 17,548,616.
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Figure 5.12 EfficientNet B0 Baseline neural network Architecture[116]
The architecture of EfficientNet baseline Neural Network is shown in Figure 5.12
EfficientNet is a very efficient high-performance convolutional neural network
architecture and scaling method that uniformly scales all dimensions of depth, width and
resolution using a compound coefficient. Where benchmark deep neural models
arbitrarily scale these factors, the EfficientNet scaling method uniformly scales network
width, depth, and resolution with a set of fixed scaling coefficients. The effectiveness of
model scaling is based on the baseline network which is playing a key role in high
performance. The baseline network builds up with a deep neural architecture search using
the AutoML MNAS framework[117], which optimizes both accuracy and efficiency.
The classification layers provide the percentage of the score for COVID-19
patients and Non-COVID-19 patients.

5.3.2 Results
The proposed deep learning model had an average detection accuracy of 91.96% on the
test CT images. Sensitivity is 92.24, Specificity is 93.01 and F1 Score is 0.90. The
following Figure 5.3.4 shows the Loss Curve. From the graph, it is evident the loss
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decreased over the epoch. Figure 5.3.5 shows the accuracy curve. From the graph, it is
evident that the accuracy improves over the epoch.

Figure 5.13 Training and Validation Loss over Epoch

Figure 5.14 Training Accuracy Vs Validation Accuracy over epoch

The following Figure 5.15, 5.16, 5.17, 5.18 are the results coming from an unknown test
sample and then matching their value for the predicted score obtained using our proposed
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model. It is clearly evident from the said figures that the predicted score clearly
confirmed the type of the class with very high accuracy.

Figure 5.15 Predicted score matching with the ground truth values.

Figure 5.16 Predicted score matching with the ground truth values.
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Figure 5.17 Predicted score matching with the ground truth values.

Figure 5.18 Predicted score matching with the ground truth values.

5.4 COVID-19 Prognosis Model using combination of Chest CT and CXR images
After successfully completed three diagnosis models on COVID-19 with different
approaches we had investigated the possibility to optimize the model in terms of deep
learning architecture, data balancing and increasing the strength and size of the sample
size. So we combine the CXR and Chest CT images and built a model which was more
efficient and accurate.
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5.4.1 Methodology

Figure 5.19 The Functional Flowchart of our Deep Neural Network Model
The Figure 5.19 illustrate the functional flowchart for our prognosis model. The
procedures were followed are as follows,
i.

We took CXR and CT both images and used it as an input in three different ways,
First only CXR, second one is CT and the third one is the combination of both.

ii.

We used vision transformer model like BEiT[118], which is a Bidirectional
Encoder representation from Image Transformers, actually a self-supervised
vision representation model which was trained in large image dataset
ImageNet[61] and optimized the trained parameters. We heuristically try different
PyTorch Vision models[119] and found that “A ConvNet for the 2020’s”[96],
outperforms every other existing models currently available, so we had
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constructed the ‘Feature Generation Architecture” for our diagnosis model using
their trained parameter network and implement the classification architecture
according to our dataset.
iii.

After successful execution we got the output as COVID-19 positive and COVID19 negative images.

5.4.2 Results
The results that we got in this work was very promising and outperform all existing
models including our all previous models.
A. Data Samples details
Table 5.2 Chest X-Ray(CXR) image sample details
Sample
Name
COVID-19
Positive
COVID-19
Negative

Train

Validation

Test

2022

1617

405

2750

2200

550

Table 5.3 Chest CT image sample details
Sample
Name
COVID-19
Positive
COVID-19
Negative

Train

Validation

Test

2713

2170

544

1314

1051

263
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Table 5.4 Combined CXR and Chest CT sample details
Sample
Name
COVID-19
Positive
COVID-19
Negative

Train

Validation

Test

4700

2841

1638

4034

2376

1409

The data sample that we had used was very large and very well balanced which help our
model to be more robust and accurate.
We got the best results using the model convnext_xlarge_in22k [96].
After 3 fold cross validation the results are as follows,
B. Results for CXR

Training Accuracy Vs Validation Accuracy
over Epoch
98
96

Accuracy

94
92
90
88
Validation Accuracy

86
84
82
80
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Epoch
Figure 5.20 Training accuracy Vs Validation accuracy over epoch
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Figure 5.20 illustrate training accuracy Vs validation accuracy over epoch for CXR
images. Here we got training accuracy 95.9376 %, validation accuracy 96.1667 % and
testing accuracy 95.1250 %.

C. Results for Chest CT

Figure 5.21 Training accuracy Vs Validation accuracy over epoch

Figure 5.21 illustrate training accuracy Vs validation accuracy over epoch for Chest CT
images. Here we got training accuracy 96.5474 %, validation accuracy 95.7302 % and
testing accuracy 97.0588 %.
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D. Results for Combined Chest CT images and CXR

Figure 5.22 Training accuracy Vs Validation accuracy over epoch

Figure 5.22 illustrate training accuracy Vs validation accuracy over epoch for Chest CT
and CXR combined images. Here we got training accuracy 95.6665 %, validation
accuracy 96.6961% and testing accuracy 97.8859 %.
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CHAPTER VI – FUTURE WORK AND CONCLUSION

The work that we had completed helped us gain a lot of knowledge for the
application of deep learning in the medical data and image analysis. The deep learning
model that we have created had potential possibility to apply to other medical disease
analysis as well as other fields. The designing of recommender system also helps medical
fraternity to take the decision more confidently and appropriately. Many earlier models
reported in the literature review section uses a limited number of COVID-19 positive
images due to the lack of availability of such data during the early stages of the
pandemic. In the present work, a large dataset of CXR and chest CT images were used
with balanced positive and negative cases. This adds to the growing body of evidence
that deep learning techniques may be used in a clinical setting with confidence for
detecting COVID-19 and other disease prognosis model design. One of the
recommendations of WHO is to increase testing for COVID-19. Usage of deep learningbased methods would bring down the cost and accelerate the diagnosis process which
will enable rapid testing on a global scale.

In our future work, we would investigate vision transformer models in more
comprehensive way with this dataset. Transformer architecture performs very well in
Natural Language Processing(NLP) tasks and is widely used in NLP domains. But
recently many research works comes up with vision applications as well, though Deep
Convolutional Neural Network is mostly preferred by most of the researchers in
computer vision applications, especially in image processing domains, object detection
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domains, etc. We also like to extend our work on our classification layers with more
variety of activation functions and loss functions.

73

REFERENCES
1. Alan M. Turing, Computing machinery and intelligence, in: Parsing the Turing Test,
Springer, 2009, pp. 23–65.
2. Stuart J. Russell, (Stuart Jonathan). Artificial Intelligence : a Modern Approach. Upper
Saddle River, N.J. :Prentice Hall, 2010.
3. Kevin Warburton, Deep learning and education for sustainability, International Journal of
Sustainability in Higher Education 4 (1) (2003) 44–56.
4. Hyeji Kim, Yihan Jiang, Ranvir Rana, Sreeram Kannan, Sewoong Oh, Pramod
Viswanath, Communication algorithms via deep learning, preprint, arXiv:1805.09317,
2018.
5. Hoang Nguyen, Le-Minh Kieu, Tao Wen, Chen Cai, Deep learning methods in
transportation domain: a review, IET Intelligent Transport Systems 12 (9) (2018) 998–
1004.
6. Andreas Kamilaris, Francesc X. Prenafeta-Boldú, Deep learning in agriculture: a survey,
Computers and Electronics in Agriculture 147 (2018) 70–90.
7. James B. Heaton, Nick G. Polson, Jan Hendrik Witte, Deep learning for finance: deep
portfolios, Applied Stochastic Models in Business and Industry 33 (1) (2017) 3–12.
8. Andre Esteva, Alexandre Robicquet, Bharath Ramsundar, Volodymyr Kuleshov, Mark
DePristo, Katherine Chou, Claire Cui, Greg Corrado, Sebastian Thrun, Jeff Dean, A
guide to deep learning in healthcare, Nature Medicine 25 (1) (2019) 24–29.
9. KC Santosh, AI-driven tools for coronavirus outbreak: need of active learning and crosspopulation train/test models on multitudinal/multimodal data, Journal of Medical Systems
44 (5) (2020) 93, https://doi.org/10. 1007/s10916-020-01562-1.
10. Sourodip Ghosh, Ahana Bandyopadhyay, Shreya Sahay, Richik Ghosh, Ishita Kundu, KC
Santosh, Colorectal histology tumor detection using ensemble deep neural network,
Engineering Applications of Artificial Intelligence 100 (2021) 104202,
https://doi.org/10.1016/j.engappai.2021.104202.
11. Somenath Chakraborty, Category identification technique by a semantic feature
generation algorithm. In: Deep learning for internet of things infrastructure. CRC Press,
pp 129–144.
12. Locatelli, "Nephrology: Main Advances in the Last 40 Years", Journal of Nephrology,
Vol. 19, pp 6-11, 2006.
13. Z. Qi et al.,"Application of Polyvinyl Alcohol (PVA) Macro-Encapsulated Isets in Islet
Transplantation," 2009 3rd International Conference on Bioinformatics and Biomedical
Engineering,Beijing,2009,pp.1-3.
14. A. K. Iyer, G. L. Zenarosa, A. J. Schaefer, C. H. Chang, C. L. Bryce and M. S. Roberts,
"A biologically based discrete-event simulation model of liver transplantation in the

74

United States for pediatric and adult patients," Proceedings of the 2011 Winter
Simulation Conference (WSC), Phoenix, AZ, 2011, pp. 1275-1282, doi:
10.1109/WSC.2011.6147848.
15. Alagoz, O., Bryce, C. L., Shechter, S., Schaefer, A., Chang, C.-C. H., Angus, D. C., &
Roberts, M. S. (2005). Incorporating Biological Natural History in Simulation Models:
Empirical Estimates of the Progression of End-Stage Liver Disease. Medical Decision
Making, 25(6), 620–632. https://doi.org/10.1177/0272989X05282719.
16. Alagoz, O., Maillart, L., Schaefer, A., & Roberts, M. (2004). The Optimal Timing of
Living-Donor Liver Transplantation. Management Science, 50(10), 1420-1430. Retrieved
June 12, 2020, from www.jstor.org/stable/30046184.
17. J. H. Fielder, "Organ transplants," in IEEE Engineering in Medicine and Biology
Magazine, vol. 16, no. 2, pp. 84-86, March-April 1997, doi: 10.1109/51.582184.
18. D. Medved, P. Nugues and J. Nilsson, "Predicting the outcome for patients in a heart
transplantation queue using deep learning," 2017 39th Annual International Conference
of the IEEE Engineering in Medicine and Biology Society (EMBC),
Seogwipo,2017,pp.74-77,doi: 10.1109/EMBC.2017.8036766.
19. A. Ravikumar, R. Saritha and V. Chandra, "Support vector machine based prognostic
analysis of renal transplantations," 2013 Fourth International Conference on Computing,
Communications and Networking Technologies (ICCCNT), Tiruchengode,2013,pp.1-6.
20. L. Al-Ebbini, A. Oztekin, Z. Sevkli and D. Delen, "Predicting quality of life for lung
transplant recipients: A hybrid genetic algorithms-basedmethodology,"2017,IEEEJordan
Conference on Applied Electrical Engineering and Computing
Technologies(AEECT),Aqaba,2017,pp.1-6.
21. C.G.Raji and S. S. Vinod Chandra, "Long-Term Forecasting the Survival in Liver
Transplantation Using Multilayer Perceptron Networks," in IEEE Transactions on
Systems, Man, and Cybernetics: Systems, vol. 47, no. 8, pp. 2318-2329, Aug. 2017, doi:
10.1109/TSMC.2017.2661996.
22. S. Muthukumaran and B. Velumani,"A Biclustering Approach for Investigating Patterns
for Breast Cancer Attributes," 2014 International Conference on Intelligent Computing
Applications, Coimbatore, 2014,pp. 22-26, doi: 10.1109/ICICA.2014.14.
23. J.A. Nepomuceno, A. Troncoso, & J.S. Aguilar-Ruiz, Biclustering of Gene Expression
Data by Correlation-Based Scatter Search. BioData Mining 4, 3 (2011).
https://doi.org/10.1186/1756-0381-4-3.
24. Doruk Bozdağ, Ashwin S. Kumar, and Umit V. Catalyurek. 2010. Comparative analysis
of bi-clustering algorithms. In Proceedings of the First ACM International Conference on
Bioinformatics and Computational Biology(BCB’10). Association for Computing
Machinery, New York, NY, USA, 265–274. https://doi.org/10.1145/1854776.1854814.
25. V. Sangeetha and J. Preethi, "Cluster analysis of breast cancer data using Genetic
Algorithm and Spiking Neural Networks," 2015 IEEE 9th International Conference on

75

Intelligent Systems and Control (ISCO), Coimbatore, 2015, pp. 1-5,
doi:10.1109/ISCO.2015.7282345.
26. T. Padhi and P. Kumar,"Breast Cancer Analysis Using WEKA," 2019 9th International
Conference on Cloud Computing, Data Science & Engineering (Confluence), Noida,
India, 2019, pp. 229-232, doi: 10.1109/CONFLUENCE.2019.8776911.
27. D. Verma and N. Mishra, "Analysis and prediction of breast cancer and diabetes disease
datasets using data mining classification techniques," 2017 International Conference on
Intelligent Sustainable Systems(ICISS), Palladam, 2017, pp. 533-538, doi:
10.1109/ISS1.2017.8389229.
28. L. M. Naeni and A. Salehipour,"Investigating a Breast Cancer Gene Expression Data
Using a Novel Clustering Approach," 2019 IEEE International Conference on Industrial
Engineering and Engineering Management (IEEM), Macao, Macao, 2019, pp. 10381042, doi:10.1109/IEEM44572.2019.8978949.
29. Taosheng Xu, Ning Su, Rujing Wang and Liangtu Song, "Gene selection for cancer
clustering analysis based on expression data," 2015 4th International Conference on
Computer Science and Network Technology (ICCSNT), Harbin, 2015, pp. 516-519,
doi:10.1109/ICCSNT.2015.7490801.
30. A. L. Fijri and Z. Rustam, "Comparison between Fuzzy Kernel C-Means and Sparse
Learning Fuzzy C-Means for Breast Cancer Clustering," 2018 International Conference
on Applied Information Technology and Innovation (ICAITI), Padang, Indonesia, 2018,
pp. 158-161, doi: 10.1109/ICAITI.2018.8686707.
31. P. H. S. Coutinho and T. P. das Chagas, "Proposal of new hybrid fuzzy clustering
algorithms—Application to breast cancer dataset," 2017 IEEE Latin American
Conference on Computational Intelligence (LA-CCI), Arequipa, 2017,pp.1-6,
doi:10.1109/LA-CCI.2017.8285679.
32. D. Wu, L. Sheng, E. Xu, K. Xing and D. Chen, "Analysis of an ensemble algorithm for
clustering cancer data," 2012 IEEE International Conference on Bioinformatics and
Biomedicine Workshops, Philadelphia, PA,2012, pp.754-755. doi:
10.1109/BIBMW.2012.6470233.
33. Chen, D., Xing, K., Henson, D., Sheng, L., Schwartz, A. M., & Cheng, X. (2009).
Developing prognostic systems of cancer patients by ensemble clustering. Journal of
biomedicine & biotechnology, 2009, 632786. https://doi.org/10.1155/2009/63278.
34. Breast Cancer Statistics and diagnosis, available at
https://www.breastcancer.org/symptoms/diagnosis
35. Diagnosis Screening Details of Breast cancer, available at
https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection.html
36. Diagnosis Screening Details of Breast cancer, available at
https://www.who.int/cancer/prevention/diagnosis-screening/en/

76

37. N. Jafarpisheh, N. Nafisi and M. Teshnehlab, "Breast cancer relapse prognosis by classic
and modern structures of machine learning algorithms," 2018 6th Iranian Joint Congress
on Fuzzy and Intelligent Systems (CFIS), Kerman, 2018, pp. 120-122, doi:
10.1109/CFIS.2018.8336649.
38. Naveen, R. K. Sharma and A. Ramachandran Nair, "Efficient Breast Cancer Prediction
Using Ensemble Machine Learning Models," 2019 4th International Conference on
Recent Trends on Electronics, Information, Communication & Technology (RTEICT),
Bangalore, India, 2019, pp. 100-104, doi:10.1109/RTEICT46194.2019.9016968.
39. H. Amitha and I. Selvamani, "A Survey on Automatic Breast Cancer Grading of
Histopathological Images," 2018 International Conference on Control, Power,
Communication and Computing Technologies (ICCPCCT), Kannur, 2018, pp. 185-189,
doi:10.1109/ICCPCCT.2018.8574291.
40. F. Imani, R. Chen, C. Tucker and H. Yang, Random Forest Modeling for Survival
Analysis of Cancer Recurrences, 2019 IEEE 15th International Conference on
Automation Science and Engineering(CASE),Vancouver, BC, Canada, 2019,pp.399-404,
doi:10.1109/COASE.2019.8843271.
41. M. Elnahas, M. Hussein and A. Keshk, Artificial Neural Network as Ensemble
Technique Fuser for Improving Classification Accuracy, 2019 Ninth International
Conference on Intelligent Computing and Information Systems (ICICIS), Cairo, Egypt,
2019, pp.174-179, doi: 10.1109/ICICIS46948.2019.9014791.
42. N. M. J. Kumari and K. K. V. Krishna, Prognosis of Diseases Using Machine Learning
Algorithms: A Survey, 2018 International Conference on Current Trends towards
Converging Technologies (ICCTCT), Coimbatore, 2018, pp. 1-9, doi:
10.1109/ICCTCT.2018.8550902.
43. Zhu W, Xie L, Han J, Guo X. The Application of Deep Learning in Cancer Prognosis
Prediction. Cancers (Basel). 2020;12(3):603. Published 2020 Mar 5.
doi:10.3390/cancers12030603.
44. B. Fu, P. Liu, J. Lin, L. Deng, K. Hu and H. Zheng, Predicting Invasive Disease-Free
Survival for Early Stage Breast Cancer Patients Using Follow-Up Clinical Data, in IEEE
Transactions on Biomedical Engineering, vol.66, no.7, pp. 2053-2064, July 2019,
doi:10.1109/TBME.2018.2882867.
45. H. Lu, H. Wang, S.W. Yoon, A dynamic gradient boosting machine using genetic
optimizer for practical breast cancer prognosis, Expert Syst. Appl.116 (2019) 340–350.
46. C. Huang; Y. Wang; X. Li; L. Ren; J. Zhao; Y. Hu; L. Zhang; G. Fan; J. Xu; X. Gu; et al.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet 2020, 395, 497–506.
47. A.S. Fauci; H.C. Lane; R.R. Redfield, COVID-19 Navigating the uncharted. N. Engl. J.
Med. 2020, 382, 1268–1269.

77

48. F. Wu; S. Zhao; B. Yu; Y.M. Chen; W. Wang; Z.G. Song; Y. Hu; Z.W. Tao; J.H. Tian;
Y.Y. Pei; et al. A new coronavirus associated with human respiratory disease in China.
Nature 2020, 579, 265–269.
49. Gavriatopoulou, M.; Korompoki, E.; Fotiou, D.; Ntanasis-Stathopoulos, I.; Psaltopoulou,
T.; Kastritis, E.; Terpos, E.; Dimopoulos, M.A. Organ-specific manifestations of COVID19 infection. Clin. Exp. Med. 2020, 20, 493–506. https://doi.org/10.1007/s10238-02000648-x.
50. W. Wang; Y. Xu; R. Gao; R. Lu; K. Han; G. Wu; W. Tan, Detection of SARS-cov-2 in
different types of clinical specimens. JAMA 2020, 323, 1843–1844.
51. A. Brihn; J. Chang ; K. OYong; S. Balter; D. Terashita; Z. Rubin; N. Yeganeh,
Diagnostic performance of an antigen test with RT-PCR for the detection of SARS-CoV2 in a hospital setting Los Angeles County, California, June-August 2020. MMWR Morb.
Mortal. Wkly. Rep. 2021, 70, 702–706. https://doi.org/10.15585/mmwr.mm7019a3.
52. T. Ai; Z. Yang; H. Hou; C. Zhan; C. Chen; W. Lv; Q. Tao; Z. Sun; L. Xia, Correlation of
chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: A
report of 1014 cases. Radiology 2020, 296, E32–E40.
https://doi.org/10.1148/radiol.2020200642.
53. L. Fan; D. Li; H. Xue; L. Zhang; Z. Liu; B. Zhang; L. Zhang; W. Yang; B. Xie; X. Duan;
et al. Progress and prospect on imaging diagnosis of COVID-19. Chin. J. Acad. Radiol.
2020, 3, 4–13. https://doi.org/10.1007/s42058-020-00031-5.
54. H.X. Bai; B. Hsieh; Z. Xiong; K. Halsey; J.W. Choi; T.M.L. Tran; I. Pan; L.B. Shi; D.C.
Wang; J. Mei; et al. Performance of radiologists in differentiating COVID-19 from viral
pneumonia on chest CT. Radiology 2020, 296, 200823.
https://doi.org/10.1148/radiol.2020200823.
55. X. He; X. Yang; S. Zhang; J. Zhao; Y. Zhang; E. Xing; P. Xie, Sample-efficient deep
learning for COVID-19 diagnosis based on CT scans. Health Inform. 2020.
https://doi.org/10.1101/2020.04.13.20063941.
56. L. Wang; Z.Q. Lin; A. Wong; COVID-Net: A tailored deep convolutional neural network
design for detection of COVID-19 cases from chest X-ray images. Sci. Rep. 2020, 10,
19549. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658227/
(accessed 10 December 2021).
57. S.A. Harmon; T. H. Sanford; S. Xu; E.B. Turkbey; H. Roth; Z. Xu; D. Yang; A.
Myronenko; V. Anderson; A. Amalou; et al. Artificial intelligence for the detection of
COVID-19 pneumonia on chest CT using multinational datasets. Nat. Commun. 2020,
11, 4080. https://doi.org/10.1038/s41467-020-17971-2.
58. D. Das; K.C. Santosh; U. Pal; Truncated inception net: COVID-19 outbreak screening
using chest X-rays. Phys. Eng. Sci. Med. 2020, 43, 915–925.
https://doi.org/10.1007/s13246-020-00888-x.

78

59. A. K. Jaiswal; P. Tiwari; S. Kumar; D. Gupta; A. Khanna; J.P.C. Rodrigues; Identifying
pneumonia in chest X-rays: A deep learning approach. Measurement 2019, 145, 511–
518. https://doi.org/10.1016/j.measurement.2019.05.076.
60. M. Annarumma; S. J. Withey; R. J. Bakewell; E. Pesce; V. Goh; Automated triaging of
adult chest radiographs with deep artificial neural networks. Radiology 2019, 291, 272–
272. https://doi.org/10.1148/radiol.2019194005.
61. A. Krizhevsky; I. Sutskever; G. E. Hinton; Imagenet classification with deep
convolutional neural networks. In Proceedings of the Advances in Neural Information
Processing Systems 25: 26th Annual Conference on Neural Information Processing
Systems, Lake Tahoe, NV, USA. 3–6 December 2012; pp. 1097–1105.
62. Y. LeCun; Y. Bengio; G. Hinton; Deep learning. Nature 2015, 521, 436–444.
63. Centers for Disease Control and Prevention. Delta variant: What We Know about the
Science. 2021. Available online: https://www.cdc.gov/coronavirus/2019ncov/variants/deltavariant.html?s_cid=11512:cdc%20delta%20variant:sem.ga:p:RG:GM:gen:PTN:FY21
(accessed on 9 December 2021).
64. Centers for Disease Control and Prevention. Omicron Variant: What You Need to Know.
2021. Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/omicronvariant.html (accessed on 9 December 2021).
65. K. He, X. Zhang, S. Ren and J. Sun, "Deep Residual Learning for Image Recognition,"
2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 2016, pp.
770-778, doi: 10.1109/CVPR.2016.90.
66. Alex Krizhevsky, Ilya Sutskever, and Geoffrey E. Hinton. 2017. ImageNet classification
with deep convolutional neural networks. Commun. ACM 60, 6 (June 2017), 84–90.
https://doi.org/10.1145/3065386.
67. G. Huang, Z. Liu, L. Van Der Maaten and K. Q. Weinberger, "Densely Connected
Convolutional Networks," 2017 IEEE Conference on Computer Vision and Pattern
Recognition (CVPR), 2017, pp. 2261-2269, doi: 10.1109/CVPR.2017.243.
68. Xiangyu Zhang, Jianhua Zou, Kaiming He, and Jian Sun. 2016. Accelerating Very Deep
Convolutional Networks for Classification and Detection. IEEE Trans. Pattern Anal.
Mach. Intell. 38, 10 (October 2016), 1943–1955.
https://doi.org/10.1109/TPAMI.2015.2502579.
69. P. Rajpurkar, J. Irvin, K. Zhu, B. Yang, H. Mehta, T. Duan, D. Ding, A. Bagul, C.
Langlotz, K. Shpanskaya, M. P. Lungren, and A. Y. Ng, CheXNet: Radiologist-level
pneumonia detection on chest Xrays with deep learning, 2017, arXiv:1711.05225.
http://arxiv.org/abs/1711.05225.
70. Wang, L., Lin, Z.Q. & Wong, A. COVID-Net: a tailored deep convolutional neural
network design for detection of COVID-19 cases from chest X-ray images. Sci Rep 10,
19549 (2020). https://doi.org/10.1038/s41598-020-76550-z.

79

71. S. Minaee, R. Kafish, M. Sonka, S. Yazdani, and G. Jamalipour Sou, Deep-COVID:
Predicting COVID-19 from chest X-ray images using deep transfer learning, Med. Image
Anal., vol. 65, Oct. 2020, Art. no. 101794.
72. A. I. Khan, J. L. Shah, and M. M. Bhat, CoroNet: A deep neural network for detection
and diagnosis of COVID-19 from chest X-ray images, Comput. Methods Programs
Biomed., vol. 196, Nov. 2020, Art. no. 105581.
73. H. Panwar et. al, A deep learning and grad-CAM based color visualization approach for
fast detection of COVID-19 cases using chest X-ray and CT-Scan images. Chaos Solitons
Fractals 140, 110190. https:// doi. org/ 10. 1016/j. chaos. 2020. 110190 (2020).
74. Xuehai He, et al., Sample-efficient deep learning for COVID-19 diagnosis based on CT
scans, Medrxiv (2020).
75. X. Wang , X. Deng, Q. Fu, et. al, A weakly-supervised framework for COVID-19
classification and lesion localization from chest CT. IEEE Trans Med Imaging
2020;39(8):2615-25.
76. Ozsahin I, Sekeroglu B, Musa MS, Mustapha MT, UzunOzsahin D. Review on Diagnosis
of COVID-19 from chest CT images using artificial intelligence, computational and
mathematical methods in medicine, Hindawi; 2020.
77. Z. Tang, et. al Severity assessment of coronavirus disease 2019 (COVID-19) using
quantitative features from chest CT images; 2020, arXiv preprint arXiv:2003.11988.
78. Ying Song, et. al, Deep learning enables accurate diagnosis of novel coronavirus
(COVID-19) with CT images, IEEE/ACM Trans. Comput. Biol. Bioinform. (2021).
79. M. Tan and Q. V. Le. (2019). EfficientNet: Rethinking Model Scaling for Convolutional
Neural Networks. ArXiv, abs/1905.11946.
80. M. Tan, B. Chen, R. Pang, V. Vasudevan, & Q.V. Le, (2019). MnasNet: Platform-Aware
Neural Architecture Search for Mobile. 2019 IEEE/CVF Conference on Computer Vision
and Pattern Recognition (CVPR), 2815-2823.
81. Hangbo Bao, Li Dong, and Furu Wei. BEiT: BERT pretraining of image transformers.
arXiv:2106.08254, 2021.
82. Francesco Pelosin, Saurav Jha, Andrea Torsello, Bogdan Raducanu, Joost van de Weijer,
Towards Exemplar-Free Continual Learning in Vision Transformers: an Account of
Attention, Functional and Weight Regularization,
https://doi.org/10.48550/arXiv.2203.13167.
83. Sayak Paul and Pin-Yu Chen. Vision transformers are robust learners. arXiv preprint
arXiv:2105.07581, 2021.
84. Ze Liu, Yutong Lin, Yue Cao, Han Hu, Yixuan Wei, Zheng Zhang, Stephen Lin, and
Baining Guo. Swin transformer: Hierarchical vision transformer using shifted windows.
In Proceedings of the IEEE/CVF International Conference on Computer Vision, 2021.

80

85. Hugo Touvron, Matthieu Cord, Matthijs Douze, Francisco Massa, Alexandre
Sablayrolles, and Herv’e J’egou. Training data-efficient image transformers & distillation
through attention. In ICML, 2021.
86. YuqingWang, Zhaoliang Xu, XinlongWang, Chunhua Shen, Baoshan Cheng, Hao Shen,
and Huaxia Xia. End-to-end video instance segmentation with transformers. 2021
IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2021.
87. Tete Xiao, Mannat Singh, Eric Mintun, Trevor Darrell, Piotr Dollar, and Ross B.
Girshick. Early convolutions help transformers see better. CoRR, abs/2106.14881, 2021.
88. Jianwei Yang, Chunyuan Li, Pengchuan Zhang, Xiyang Dai, Bin Xiao, Lu Yuan, and
Jianfeng Gao. Focal self-attention for local-global interactions in vision transformers.
ArXiv, abs/2107.00641, 2021.
89. Pei Yu, Yinpeng Chen, Ying Jin, and Zicheng Liu. Improving vision transformers for
incremental learning. CoRR, abs/2112.06103, 2021.
90. S.H. Ebenuwa; M.S. Sharif; M. Alazab; A.A. Nemrat, Variance ranking attributes
selection techniques for binary classification problem in imbalance data. IEEE Access
2019, 7, 24649–24666. https://doi.org/10.1109/ACCESS.2019.2899578.
91. M. Khushi; K. Shaukat; T.A. Alam; I.A. Hameed; S. Uddin; S. Luo; X. Yang; M.C.
Reyes, A comparative performance analysis of data resampling methods on imbalance
medical data. IEEE Access 2021, 9, 109960–109975.
https://doi.org/10.1109/ACCESS.2021.3102399.
92. H. Jegierski; S. Saganowski, An “Outside the Box” solution for imbalanced data
classification. IEEE Access. 2020, 8, 125191–125209.
https://doi.org/10.1109/ACCESS.2020.3007801.
93. T. Alam; C.F. Ahmed; S.A. Zahin; M.A.H. Khan; M.T. Islam, An effective recursive
technique for multi-class classification and regression for imbalanced data. IEEE Access
2019, 7, 127615–127630. https://doi.org/10.1109/ACCESS.2019.2939755.
94. J. Maillo; I. Triguero; F. Herrera, Redundancy and complexity metrics for big data
classification: Towards smart data. IEEE Access 2020, 8, 87918–87928.
https://doi.org/10.1109/ACCESS.2020.2991800.
95. Y. Lu; Y.M. Cheung; Y.Y. Tang, Bayes imbalance impact index: A measure of class
imbalanced data set for classification problem. IEEE Trans. Neural Netw. Learn. 2020,
31, 3525–3539. https://doi.org/10.1109/TNNLS.2019.2944962.
96. Zhuang Liu, Hanzi Mao, Chao-Yuan Wu, Christoph Feichtenhofer, Trevor Darrell,
Saining Xie, A ConvNet for the 2020s, https://doi.org/10.48550/arXiv.2201.03545.
97. S. Chakraborty and C. Zhang, "Survival Prediction Model of Renal Transplantation using
Deep Neural Network," 2020 IEEE 1st International Conference for Convergence in
Engineering (ICCE), 2020, pp. 180-183, doi: 10.1109/ICCE50343.2020.9290695.
98. V. Hegde, S. Usmani, “Parallel and Distributed Deep Learning”.

81

99. F. Chollet et. al, (2015). Keras. GitHub. Retrieved from https://github.com/fchollet/keras
100. C. Nardone, “Introduction to GPU Programming,” NVIDIA EMEA.
101. Somenath Chakraborty, Beddhu Murali, Investigate the Correlation of Breast Cancer
Dataset using Different Clustering Technique, https://doi.org/10.48550/arXiv.2109.01538.
102. Chakraborty, S., Murali, B. (2022). A Novel Medical Prognosis System for Breast
Cancer. In: Mandal, J.K., Buyya, R., De, D. (eds) Proceedings of International Conference
on Advanced Computing Applications. Advances in Intelligent Systems and Computing,
vol 1406. Springer, Singapore. https://doi.org/10.1007/978-981-16-5207-3_34.
103. L. Kaufman, P. Rousseeuw, Partitioning around medoids (Program PAM), Wiley Series
in Probability and Statistics, Wiley (1990).
104. L. Kaufman, & P. J. Rousseeuw, (1990). Finding groups in data: An introduction to
cluster analysis. New York: Wiley.
105. J. R. Quinlan, C4.5: Programs for Machine Learning. Morgan Kaufmann Publishers,
1993.
106. Praveen. Corona Hack-Chest X-Ray-Dataset.
Available online: https://www.kaggle.com/praveengovi/coronahack-chest-xraydataset
107. Cohen, J.P.; Morrison, P.; Dao, L. COVID-19 Image Data Collection. arXiv 2020,
arXiv:2003.11597. Available online: https://arxiv.org/abs/2003.11597
108. Paul, C.J. COVID-19 Image Data Collection. 2020. Available online:
https://github.com/ieee8023/covid-chestxray-dataset.
109. Paul, M. Kaggle Chest X-ray Images (Pneumonia) Dataset. 2020. Available online:
https://www.kaggle.com/paultimothymooney/chest-xray-pneumonia
110. B. V. Ginneken; M.B. Stegmann; M. Loog, Segmentation of anatomical structures in
chest radiographs using supervised methods: A comparative study on a public database.
Med. Image Anal. 2006, 10, 19–40.
111. S. Jaeger; S. Candemir; S. Antani; Y. X. J. Wang; P.X. Lu; G. Thoma; Two public chest
X-ray datasets for computer aided screening of pulmonary diseases, Quant. Imag. Med.
Surg. 2014, 4, 475.
112. S. Jegou; M. Drozdzal; D. Vazquez; A. Romero; Y. Bengio; The one hundred layers
tiramisu: Fully convolutional DenseNets for semantic segmentation. In Proceedings of the
IEEE Computer Society Conference on Computer Vision and Pattern Recognition
Workshops, Honolulu, HI, USA, 21–26 July 2017; pp. 1175–1183.
https://doi.org/10.1109/CVPRW.2017.156.

82

113. J. Deng, W. Dong, R. Socher, L. -J. Li, Kai Li and Li Fei-Fei, "ImageNet: A large-scale
hierarchical image database," 2009 IEEE Conference on Computer Vision and Pattern
Recognition, 2009, pp. 248-255, doi: 10.1109/CVPR.2009.5206848.
114. A. Paszke; S. Gross; F. Massa; A. Lerer; J. Bradbury; G. Chanan; et al. PyTorch: An
Imperative Style, High-Performance Deep Learning Library. In: Advances in Neural
Information Processing Systems 32 [Internet]. Curran Associates, Inc.; 2019. p. 8024–35.
Available from: http://papers.neurips.cc/paper/9015-pytorch-an-imperative-style-highperformance-deep-learning-library.pdf
115. Olaf Ronneberger; Philipp Fischer; Thomas Brox,(2015); "U-Net: Convolutional
Networks for Biomedical Image Segmentation". arXiv:1505.04597.
116. M. Tan; & Q. V. Le; (2019). EfficientNet: Rethinking Model Scaling for Convolutional
Neural Networks. ArXiv, abs/1905.11946.
117. M. Tan; B. Chen; R. Pang; V. Vasudevan & Q. V. Le; (2019). MnasNet: Platform-Aware
Neural Architecture Search for Mobile. 2019 IEEE/CVF Conference on Computer Vision
and Pattern Recognition (CVPR), 2815-2823.
118. Hangbo Bao, Li Dong, Furu Wei, BEiT: BERT Pre-Training of Image Transformers,
available at: https://doi.org/10.48550/arXiv.2106.08254.
119. PyTorch Vision Models. Available at: https://pytorch.org/vision/stable/models.html.

83

